Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Statins beneficial for diabetics

This article was originally published in The Tan Sheet

Executive Summary

Statin therapy is safe and cost-effective option for reducing the risk of major vascular events in patients with diabetes and should be considered for almost all diabetics, according to a meta-analysis by the Cholesterol Treatment Trialists' Collaborators. The study, which was published in The Lancet Jan. 12 and included 14 trials with 18,686 diabetics and 17,220 non-diabetics, found statin therapy in diabetics was associated with a 9 percent proportional reduction in all-cause mortality per mmol/L reduction in LDL cholesterol, and was associated with a statistically similar 13 percent reduction in all-cause mortality in those without diabetes...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel